Dr. Say Sreypich is currently serving as a full-time faculty member in the Master’s Program at the University of Puthisastra, Cambodia. She previously held a postdoctoral research position at the School of Medicine, Keio University, Japan. Dr. Sreypich earned her Doctor of Philosophy in Engineering, majoring in Biomedical Science and Engineering, from Tokyo Medical and Dental University, Japan, in 2024. She also holds a Master’s degree in Chemical Engineering from De La Salle University, Philippines (2018), and an Engineering degree in Chemical Engineering and Food Science from the Institute of Technology of Cambodia (2011). Her research interests lie in the development of biomaterials for medical applications, particularly through decellularization technology, 3D printing, and hydrogel formation. She is also actively engaged in the study of biomaterials under in vitro, in vivo, and ex vivo conditions, with a focus on their mechanical and surface properties.

Dr. Maryam Farokhi holds a Ph.D. in Biomedical Engineering (Biomaterials) from Amir Kabir University of Technology, Tehran, Iran. Her research focuses on biomaterials, tissue engineering, drug delivery systems, and 3D printing, with a specialization in silk fibroin hydrogels for cartilage regeneration. She has published several papers in high-impact journals, presented at international conferences, and served as a teaching assistant in Biomaterial Science.

Dr. Rajesh Selvaraj is a postdoctoral researcher at the Joan C. Edwards School of Medicine, Marshall University, USA. He earned his Ph.D. in Zoology from Presidency College, University of Madras, India. His academic and research background spans molecular biology, biochemistry, and bioinformatics, with a strong focus on the anticancer properties of natural compounds. His doctoral work investigated bioactive compounds from Cardiospermum halicacabum for their potential against hepatocellular carcinoma.

Joy Kong, M.D. is a UCLA-trained, triple board-certified physician (American Board of Psychiatry & Neurology, American Board of Addiction Medicine, American Board of Anti- Aging & Regenerative Medicine). She is the president of Chara Health in Los Angeles, California, where she specializes in stem cell therapy, ketamine therapy, as well as a wide range of therapeutic modalities to improve patients’ overall health by enhancing their body’s innate regenerative potentials.Dr. Kong is an avid educator and the founder of American Academy of Integrative Cell Therapy, where she provides training and mentorship to physicians in the arena of stem cell therapy. Dr.Kong is keen in her pursuit of evidence-based medicine, and is a published author in scientific journals. Dr. Kong is a sought-after speaker nationally and internationally. and is a faculty member for International Society for Stem Cell Application (ISSCA) - the largest international stem cell training organization that has trained thousands of physicians worldwide. In an effort to provide her patients with the best regenerative medicine products, Dr. Kong founded Chara Biologics, where she developed the most potent and comprehensive stem cell product in the country with a patent-pending formulation, as well as a 100% natural stem cell skin cream CharaOmni. Dr. Kong was recognized for her contribution to the field of regenerative medicine and awarded the "Top Doctor of the Year in Stem Cell Therapy” in 2019 as well as “Stem Cell Doctor of the Decade” in 2021 by the prestigious IAOTP (International Association of Top Professionals). Dr. Kong’s memoir Tiger of Beijing has garnered tremendous interest, and was named “2020 Book of the Year” and showcased at Times Square. Dr. Kong was also featured in the 2021 book HEROES, LEADERS, LEGENDS: the Power of the Human Spirit, along with movers and shakers such as Oprah Winfrey, Deepak Chopra and Maya Angelo.